Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: A randomized, placebo-controlled trial
- 1 October 1996
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 101 (4) , 341-348
- https://doi.org/10.1016/s0002-9343(96)00227-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of two oral doses of alendronate in the treatment of Paget's disease of boneBone, 1994
- Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of boneBone and Mineral, 1994
- Determinants of remission of paget's disease of boneJournal of Bone and Mineral Research, 1993
- Pamidronate is effective for paget's disease of bone refractory to conventional therapyCalcified Tissue International, 1993
- Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responsesClinical Endocrinology, 1991
- Treatment of paget's disease of bone with aminohydroxybutylidene bisphosphonateJournal of Bone and Mineral Research, 1990
- TREATMENT OF PAGET'S DISEASE OF BONEClinical Endocrinology, 1990
- Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).BMJ, 1987
- Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonateCalcified Tissue International, 1986
- Diphosphonate Therapy of Paget's Disease of BoneJournal of Clinical Endocrinology & Metabolism, 1977